OpenURL Connection Search

Select item for more details and to access through your institution.

Reliability of histologic assessment in patients with eosinophilic oesophagitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 7, p. 940, doi. 10.1111/apt.14559
By:
- Warners, M. J.;
- Ambarus, C. A.;
- Bredenoord, A. J.;
- Verheij, J.;
- Lauwers, G. Y.;
- Walsh, J. C.;
- Katzka, D. A.;
- Nelson, S.;
- van Viegen, T.;
- Furuta, G. T.;
- Gupta, S. K.;
- Stitt, L.;
- Zou, G.;
- Parker, C. E.;
- Shackelton, L. M.;
- D`Haens, G. R.;
- Sandborn, W. J.;
- Dellon, E. S.;
- Feagan, B. G.;
- Collins, M. H.
Publication type:
Article
The development of a magnetic resonance imaging index for fistulising Crohn's disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 5, p. 516, doi. 10.1111/apt.14190
By:
- Samaan, M. A.;
- Puylaert, C. A. J.;
- Levesque, B. G.;
- Zou, G. Y.;
- Stitt, L.;
- Taylor, S. A.;
- Shackelton, L. M.;
- Vandervoort, M. K.;
- Khanna, R.;
- Santillan, C.;
- Rimola, J.;
- Hindryckx, P.;
- Nio, C. Y.;
- Sandborn, W. J.;
- D'Haens, G.;
- Feagan, B. G.;
- Jairath, V.;
- Stoker, J.
Publication type:
Article
Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 3, p. 292, doi. 10.1111/apt.14164
By:
- D'Haens, G. R.;
- Sandborn, W. J.;
- Zou, G.;
- Stitt, L. W.;
- Rutgeerts, P. J.;
- Gilgen, D.;
- Jairath, V.;
- Hindryckx, P.;
- Shackelton, L. M.;
- Vandervoort, M. K.;
- Parker, C. E.;
- Muller, C.;
- Pai, R. K.;
- Levchenko, O.;
- Marakhouski, Y.;
- Horynski, M.;
- Mikhailova, E.;
- Kharchenko, N.;
- Pimanov, S.;
- Feagan, B. G.
Publication type:
Article
Review article: dose optimisation of infliximab for acute severe ulcerative colitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 5, p. 617, doi. 10.1111/apt.13913
By:
- Hindryckx, P.;
- Novak, G.;
- Vande Casteele, N.;
- Laukens, D.;
- Parker, C.;
- Shackelton, L. M;
- Narula, N.;
- Khanna, R.;
- Dulai, P.;
- Levesque, B. G;
- Sandborn, W. J;
- D'Haens, G.;
- Feagan, B. G.;
- Jairath, V.
Publication type:
Article
Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2016, v. 44, n. 2, p. 157, doi. 10.1111/apt.13653
By:
- Sandborn, W. J.;
- Bhandari, B. R.;
- Fogel, R.;
- Onken, J.;
- Yen, E.;
- Zhao, X.;
- Jiang, Z.;
- Ge, D.;
- Xin, Y.;
- Ye, Z.;
- French, D.;
- Silverman, J. A.;
- Kanwar, B.;
- Subramanian, G. M.;
- McHutchison, J. G.;
- Lee, S. D.;
- Shackelton, L. M.;
- Pai, R. K.;
- Levesque, B. G.;
- Feagan, B. G.
Publication type:
Article
A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 10, p. 1126, doi. 10.1111/apt.12733
By:
- Levesque, B. G.;
- Greenberg, G. R.;
- Zou, G.;
- Sandborn, W. J.;
- Singh, S.;
- Hauenstein, S.;
- Ohrmund, L.;
- Wong, C. J.;
- Stitt, L. W.;
- Shackelton, L. M.;
- King, D.;
- Lockton, S.;
- Ducharme, J.;
- Feagan, B. G.
Publication type:
Article

Found: 6

Reliability of histologic assessment in patients with eosinophilic oesophagitis.

The development of a magnetic resonance imaging index for fistulising Crohn's disease.

Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitis.

Review article: dose optimisation of infliximab for acute severe ulcerative colitis.

Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis.

A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease.